| Literature DB >> 12141961 |
Benoit Durand1, Véronique Chevalier, Régis Pouillot, Jacques Labie, Ingrid Marendat, Bernadette Murgue, Hervé Zeller, Stéphan Zientara.
Abstract
During late summer and autumn 2000, a West Nile fever outbreak in southern France resulted in 76 equine clinical cases; 21 horses died. We report the results of a large serosurvey of all equines within a 10-km radius of laboratory-confirmed cases. Blood samples were obtained from 5,107 equines, distributed in groups of 1 to 91 animals. West Nile virus immunoglobulin (Ig) G antibodies were found in 8.5% of animals (n=432). Forty-two percent of the IgG-positive animals were also IgM positive. Horses living in small groups were more affected than those in large groups. The results suggest that West Nile virus is not endemic in the affected area, the Camargue; rather, sporadic outbreaks are separated by long silent periods.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12141961 PMCID: PMC2732513 DOI: 10.3201/eid0808.010486
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Figure 1West Nile virus clinical infection in equines in southern France, 1962–2000.
Figure 2West Nile virus serosurvey, Camargue, France, 2000: number of samples and seropositive animals, by week.
Figure 3West Nile virus serosurvey, Camargue, France, 2000: geographic distribution of the animals sampled, by commune (n=5,905).
Figure 4Immunoglobulin G anti-West Nile virus prevalence in 5,095 equines, by commune, Camargue, France, 2000 (n=5,095).
Immunoglobulin G anti-West Nile virus prevalence in equines by age group, Camargue, France, 2000a
| Age (yrs) | Total | Positive (%) |
|---|---|---|
| <1 | 33 | 2 (6.1) |
| 1–2 | 368 | 44 (12.0) |
| 3–5 | 938 | 88 (9.4) |
| 6–10 | 1,559 | 124 (8.0) |
| 11–15 | 975 | 87 (8.9) |
| 16–20 | 555 | 50 (9.0) |
| 21–25 | 229 | 21 (9.2) |
| >25 | 92 | 9 (9.8) |
| Total | 4,749 | 425 (8.9) |
aChi square = 6.63 (7 degrees of freedom); p=0.47.
Immunoglobulin G anti-West Nile virus prevalence in equines by breed, Camargue, France, 2000a
| Breed class | Total | Positive (%) | Prevalence Ratio | 95% CI |
|---|---|---|---|---|
| Pure breeds | 1,252 | 108 (8.6) | 1.2 | 0.9 to 1.7 |
| Camargue | 1,743 | 183 (10.5) | 1.5 | 1.2 to1.9 |
| Ponies | 497 | 38 (7.6) | 1.0 | 0.7 to1.5 |
| Other | 1,375 | 100 (7.3) | Ref. | |
| Total | 4,867 | 429 (8.8) |
aChi square=11.12 (3 degrees of freedom), p=0.01; 95% CI = 95% confidence intervals.
Immunoglobulin G anti-West Nile virus individual-level prevalence in equines by group size, Camargue, France, 2000a
| Group size | Total | Positive (%) | Prevalence Ratio | 95% CI |
|---|---|---|---|---|
| 1–2 animals | 1,353 | 165 (12.2) | 2.2 | 1.6 to 3.0 |
| 3–6 animals | 1,118 | 114 (10.2) | 1.8 | 1.3 to 2.5 |
| 7–25 animals | 1,355 | 87 (6.4) | 1.1 | 0.8 to 1.5 |
| >25 animals | 1,281 | 55 (5.1) | Ref. | |
| Total | 5,107 | 432 (9.7) |
a Chi square = 54.11 (3 degrees of freedom), p<0.0001; 95% CI = 95% confidence intervals.
Immunoglobulin G anti-West Nile virus group-level prevalence in equines by group size, Camargue, France, 2000a
| Size class | Total | Positive (%) | Prevalence Ratio | 95% CI |
|---|---|---|---|---|
| 1–2 | 1,006 | 149 (14.8%) | Ref. | |
| 3–6 | 294 | 73 (24.8%) | 1.9 | 1.4-2.6 |
| 7–25 | 98 | 40 (40.8%) | 4.0 | 2.6-6.1 |
| >25 | 31 | 12 (38.7%) | 3.6 | 1.7-7.6 |
| Total | 1,429 | 274 (19.2%) |
a Chi square = 55.68 (3 degrees of freedom), p<0.0001.
Immunoglobulin G anti-West Nile virus prevalence in equines, by age, sex, breed, and group size, Camargue, France, 2000
| Variable | OR estimatea | 95% CI |
|---|---|---|
| Age (years) | ||
| <1 | Ref | |
| 1–2 | 1.83 | 0.42 to7.99 |
| 3–5 | 1.39 | 0.32 to 5.98 |
| 6–10 | 1.13 | 0.26 to 4.86 |
| 11–15 | 1.25 | 0.29 to 5.41 |
| 16–20 | 1.24 | 0.28 to 5.43 |
| 21–25 | 1.20 | 0.26 to 5.48 |
| >25 | 1.24 | 0.25 to 6.15 |
| Sex | ||
| Mare | Ref. | |
| Gelding | 1.13 | 0.89 to 1.45 |
| Stallion | 1.18 | 0.88 to 1.58 |
| Breed | ||
| Pure breeds | 1.30 | 0.97 to 1.74 |
| Camargue | 1.40 | 1.08 to 1.82 |
| Ponies | 1.15 | 0.77 to 1.72 |
| Other | Ref. | |
| Group size | ||
| 1–2 | 2.18 | 1.60 to 2.96 |
| 3–6 | 1.81 | 1.31 to 2.52 |
| 7–25 | 1.09 | 0.77 to 1.53 |
| >25 | Ref. | |
aOR, odds ratio; 95% CI, 95% confidence intervals.